LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Radicicol | 3.33 | uM | LJP6 | 2 | K08 | 72 | hr | 2543 | 2034 | 5438 | 0.3740 | -0.1844 |
SK-BR-3 | Radicicol | 3.33 | uM | LJP6 | 3 | K08 | 72 | hr | 2543 | 2039 | 5557 | 0.3669 | -0.1780 |
SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 1 | K08 | 72 | hr | 2543 | 2124 | 5734 | 0.3704 | -0.1424 |
SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 2 | K08 | 72 | hr | 2543 | 2468 | 5761 | 0.4284 | -0.0252 |
SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 3 | K08 | 72 | hr | 2543 | 2103 | 5760 | 0.3651 | -0.1489 |
SK-BR-3 | Radicicol | 10 | uM | LJP6 | 1 | K07 | 72 | hr | 2543 | 1963 | 5258 | 0.3733 | -0.2190 |
SK-BR-3 | Radicicol | 10 | uM | LJP6 | 2 | K07 | 72 | hr | 2543 | 2172 | 5438 | 0.3994 | -0.1341 |
SK-BR-3 | Radicicol | 10 | uM | LJP6 | 3 | K07 | 72 | hr | 2543 | 1804 | 5557 | 0.3246 | -0.2626 |
SK-BR-3 | Radicicol | 10 | uM | LJP5 | 1 | K07 | 72 | hr | 2543 | 2294 | 5734 | 0.4000 | -0.0843 |
SK-BR-3 | Radicicol | 10 | uM | LJP5 | 2 | K07 | 72 | hr | 2543 | 2279 | 5761 | 0.3956 | -0.0889 |
SK-BR-3 | Radicicol | 10 | uM | LJP5 | 3 | K07 | 72 | hr | 2543 | 2260 | 5760 | 0.3923 | -0.0953 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 2543 | 6093 | 5258 | 1.1586 | 1.3017 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 2 | G18 | 72 | hr | 2543 | 5782 | 5438 | 1.0632 | 1.1150 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 3 | G18 | 72 | hr | 2543 | 5552 | 5557 | 0.9990 | 0.9983 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 2543 | 5714 | 5734 | 0.9964 | 0.9939 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 2543 | 5861 | 5761 | 1.0173 | 1.0293 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 2543 | 5500 | 5760 | 0.9547 | 0.9230 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 2543 | 5098 | 5258 | 0.9694 | 0.9416 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 2543 | 4872 | 5438 | 0.8959 | 0.8092 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 2543 | 5027 | 5557 | 0.9046 | 0.8298 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 2543 | 5324 | 5734 | 0.9284 | 0.8773 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 2543 | 5363 | 5761 | 0.9309 | 0.8821 |
SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 2543 | 5389 | 5760 | 0.9355 | 0.8900 |
SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 2543 | 2949 | 5258 | 0.5608 | 0.1516 |
SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 2543 | 2946 | 5438 | 0.5417 | 0.1434 |